| Palbociclib | Approved Investigational | AURKA | 6790 |
downregulated | palbociclib results in decreased expression of AURKA mRNA | 20q13.2 | |
| Palbociclib | Approved Investigational | AURKB | 9212 |
downregulated | palbociclib results in decreased expression of AURKB mRNA | 17p13.1 | |
| Palbociclib | Approved Investigational | BARD1 | 580 |
downregulated | palbociclib results in decreased expression of BARD1 mRNA | 2q35 | |
| Palbociclib | Approved Investigational | BIRC5 | 332 |
downregulated | palbociclib results in decreased expression of BIRC5 mRNA | 17q25.3 | |
| Palbociclib | Approved Investigational | BORA | 79866 |
downregulated | palbociclib results in decreased expression of BORA mRNA | 13q21.33 | |
| Palbociclib | Approved Investigational | BUB1 | 699 |
downregulated | palbociclib results in decreased expression of BUB1 mRNA | 2q13 | |
| Palbociclib | Approved Investigational | CCNA2 | 890 |
downregulated | palbociclib results in decreased expression of CCNA2 mRNA | 4q27 | |
| Palbociclib | Approved Investigational | CCNB1 | 891 |
downregulated | palbociclib results in decreased expression of CCNB1 mRNA | 5q13.2 | |
| Palbociclib | Approved Investigational | CCNB2 | 9133 |
downregulated | palbociclib results in decreased expression of CCNB2 mRNA | 15q22.2 | |
| Palbociclib | Approved Investigational | CCNE2 | 9134 |
downregulated | palbociclib analog results in decreased expression of CCNE2 mRNA | 8q22.1 | |
| Palbociclib | Approved Investigational | CCNE2 | 9134 |
downregulated | palbociclib results in decreased expression of CCNE2 mRNA | 8q22.1 | |
| Palbociclib | Approved Investigational | CCNF | 899 |
downregulated | palbociclib results in decreased expression of CCNF mRNA | 16p13.3 | |
| Palbociclib | Approved Investigational | CDC20 | 991 |
downregulated | palbociclib results in decreased expression of CDC20 mRNA | 1p34.2 | |
| Palbociclib | Approved Investigational | CDC25A | 993 |
downregulated | palbociclib results in decreased expression of CDC25A mRNA | 3p21.31 | |
| Palbociclib | Approved Investigational | CDC25C | 995 |
downregulated | palbociclib results in decreased expression of CDC25C mRNA | 5q31.2 | |
| Palbociclib | Approved Investigational | CDC45 | 8318 |
downregulated | palbociclib results in decreased expression of CDC45 mRNA | 22q11.21 | |
| Palbociclib | Approved Investigational | CDCA3 | 83461 |
downregulated | palbociclib results in decreased expression of CDCA3 mRNA | 12p13.31 | |
| Palbociclib | Approved Investigational | CDCA5 | 113130 |
downregulated | palbociclib results in decreased expression of CDCA5 mRNA | 11q13.1 | |
| Palbociclib | Approved Investigational | CDCA8 | 55143 |
downregulated | palbociclib results in decreased expression of CDCA8 mRNA | 1p34.3 | |
| Palbociclib | Approved Investigational | CDK1 | 983 |
downregulated | palbociclib analog results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Palbociclib | Approved Investigational | CDK1 | 983 |
downregulated | palbociclib results in decreased expression of CDK1 mRNA | 10q21.2 | |
| Palbociclib | Approved Investigational | CDKN1B | 1027 |
upregulated | palbociclib results in increased expression of CDKN1B mRNA | 12p13.1 | |
| Palbociclib | Approved Investigational | CDKN3 | 1033 |
downregulated | palbociclib results in decreased expression of CDKN3 mRNA | 14q22.2 | |
| Palbociclib | Approved Investigational | CDT1 | 81620 |
downregulated | palbociclib results in decreased expression of CDT1 mRNA | 16q24.3 | |
| Palbociclib | Approved Investigational | CENPA | 1058 |
downregulated | palbociclib results in decreased expression of CENPA mRNA | 2p23.3 | |